(11) 98705-3426
TrademarkIQ íconeTrademarkIQ
Voltar para busca
Dado oficial do USPTO

CHROMOPLEX

Sabia que essa marca já está registrada no Estados Unidos?

Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.

Active USPTO registrationTipo: VerbalEscritório: US

Snapshot rápido

CHROMOPLEX

ST13

US500000085397962

Classe

1, 5, 42

Pedido

85397962

Registro

4710212

Diagnóstico de risco e oportunidade

Leitura executiva para decisão de naming, protocolo e monitoramento.

Atenção: há risco ativo

Situação USPTO

Active USPTO registration

Tipo de processo

Pedido e registro

Eventos registrados

72

Atualização mais recente

12/09/2025

Classificação

Registrada

Tipo de marca

Verbal

Classes Nice

1, 5, 42

Data de depósito

15/08/2011

Data de registro

31/03/2015

Data de expiração

-

Ação recomendada

Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.

Próximo passo

Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.

Dados completos do processo

Campos estruturados da autoridade responsável e do histórico oficial.

Data da situação

11/09/2025

Última transação

12/09/2025

Escritório responsável

United States Patent and Trademark Office

Código da situação

800

Cadastro oficial

Principal Register

Fundamento do pedido

Intent to use

Código do desenho

4

Tipo de titular

99

Localização do titular

NEWCASTLE UPON TYNE, GB

Examinador

GARTNER, JOHN

Titulares e representantes

Titulares

Leica Biosystems Newcastle Limited
Leica Biosystems Newcastle Limited

Representantes

Jessica G. McDonald Schwegman Lundberg & Woessner P.A.

Classificação técnica

Classes Nice

Classe 1Classe 5Classe 42

Códigos Vienna

Sem códigos Vienna disponíveis.

Produtos e serviços

Classe 1

Chemical preparations for scientific purposesincluding diagnosticresearch and laboratory purposes; chemical diagnostic preparations for scientific or research use; chemical reagents for non-medical purposesfor laboratory research use; reagents for research purposes; diagnostic preparations containing antibodies for scientific or laboratory use

Classe 5

diagnostic preparations in the nature of antibodiesfor medical and veterinary purposes; reagents and diagnostic reagents for medical or veterinary purposes; diagnostic preparations in the nature of in situ hybridization probesfor medical and veterinary purposes; diagnostic preparations in the nature of epitope retrieval solutionsfor medical and veterinary purposes; enzymes and enzyme preparations for medical diagnostic purposes; diagnostic preparations in the nature of histological dye and stain solutionsfor medical and veterinary purposes; doubletriplemultiple immunohistochemical reagents for stainingfor medical use; diagnostic preparations in the nature of doubletriple or multiple in situ hybridization application of multiple antibodies or probes in the same staining procedure to a tissue section during IHC stainingfor medical and veterinary purposes; chemical diagnostic preparations for medical and veterinary purposes

Classe 42

Scientific and technological servicesresearch and design in the field of testinganalyzingexamining or storing biological samplesmedical samplescell samples; scientific researchconducting clinical trials for others; industrial analysis and research servicesscientific research services for medical purposeslaboratory biological researchclinical biological researchbiological research and research relating to the testing of biological samplesmedical samplescell samples

Publicações

Histórico de despachos e eventos da marca no USPTO.

72 publicações encontradas

NP89

NOTICE OF ACCEPTANCE OF PARTIAL SEC. 8 & 9 EMAILED

11/09/2025

RNL1

REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)

11/09/2025

9G8P

REGISTERED - SEC. 9 GRANTED/CHECK RECORD FOR SEC. 8

11/09/2025

8PRT

REGISTERED - PARTIAL SEC. 8 (10-YR) ACCEPTED

11/09/2025

EROP

TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED

26/08/2025

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

20/08/2025

ECDR

TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS

20/08/2025

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

20/08/2025

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

20/08/2025

CHAN

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

20/08/2025

COAR

TEAS CHANGE OF OWNER ADDRESS RECEIVED

20/08/2025

PR89

POST REGISTRATION ACTION MAILED - SEC. 8 & 9

06/08/2025

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

01/08/2025

E89R

TEAS SECTION 8 & 9 RECEIVED

13/03/2025

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

01/11/2024

ECDR

TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS

01/11/2024

EWOR

TEAS WITHDRAWAL AS DOMESTIC REPRESENTATIVE RECEIVED

01/11/2024

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

01/11/2024

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

01/11/2024

CHAN

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

01/11/2024

COAR

TEAS CHANGE OF OWNER ADDRESS RECEIVED

01/11/2024

REM2

COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED

31/03/2024

NA85

NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED

27/07/2021

C15A

REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.

27/07/2021

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

22/07/2021

E815

TEAS SECTION 8 & 15 RECEIVED

17/03/2021

REM1

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED

31/03/2020

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

17/08/2017

R.PR

REGISTERED-PRINCIPAL REGISTER

31/03/2015

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

13/01/2015

PUBO

PUBLISHED FOR OPPOSITION

13/01/2015

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

24/12/2014

ATRQ

ATTORNEY REVIEW/DECISION ON AMENDMENT REQUIRED

25/11/2014

PCBG

PETITION TO DIRECTOR - CHANGE BASIS - GRANTED

22/11/2014

APET

ASSIGNED TO PETITION STAFF

19/11/2014

IUCN

NOTICE OF ALLOWANCE CANCELLED

12/11/2014

EEXT

SOU TEAS EXTENSION RECEIVED

10/11/2014

TPAD

TEAS PETITION TO AMEND BASIS RECEIVED

10/11/2014

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

14/05/2014

EX1G

SOU EXTENSION 1 GRANTED

12/05/2014

EXT1

SOU EXTENSION 1 FILED

12/05/2014

EEXT

SOU TEAS EXTENSION RECEIVED

12/05/2014

NOAM

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

12/11/2013

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

17/09/2013

PUBO

PUBLISHED FOR OPPOSITION

17/09/2013

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

28/08/2013

PREV

LAW OFFICE PUBLICATION REVIEW COMPLETED

12/08/2013

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

08/08/2013

XAEC

EXAMINER'S AMENDMENT ENTERED

08/08/2013

GNEN

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

08/08/2013

GNEA

EXAMINERS AMENDMENT E-MAILED

08/08/2013

CNEA

EXAMINERS AMENDMENT -WRITTEN

08/08/2013

GNFN

NOTIFICATION OF FINAL REFUSAL EMAILED

08/02/2013

GNFR

FINAL REFUSAL E-MAILED

08/02/2013

CNFR

FINAL REFUSAL WRITTEN

08/02/2013

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

31/01/2013

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

31/01/2013

ALIE

ASSIGNED TO LIE

28/01/2013

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

23/01/2013

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

23/07/2012

GNRT

NON-FINAL ACTION E-MAILED

23/07/2012

CNRT

NON-FINAL ACTION WRITTEN

23/07/2012

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

28/06/2012

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

28/06/2012

ALIE

ASSIGNED TO LIE

22/06/2012

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

11/06/2012

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

14/12/2011

GNRT

NON-FINAL ACTION E-MAILED

14/12/2011

CNRT

NON-FINAL ACTION WRITTEN

14/12/2011

DOCK

ASSIGNED TO EXAMINER

06/12/2011

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

18/08/2011

NWAP

NEW APPLICATION ENTERED

18/08/2011

Proteção contínua da sua marca

Seja avisado a cada novo depósito que ameace CHROMOPLEX ou a sua marca.

Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.